{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T10:07:45Z","timestamp":1747908465639,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":10,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071629451"},{"type":"electronic","value":"9781071629468"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-2946-8_5","type":"book-chapter","created":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T03:50:25Z","timestamp":1674273025000},"page":"61-69","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Urinary Glycosaminoglycans: Characterization and Quantification"],"prefix":"10.1007","author":[{"given":"Naima","family":"Fdil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Es-Said","family":"Sabir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,21]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","unstructured":"Fdil N, Sabir E-S, Ezoubeiri A et al (2020) Implementation of an affordable method for MPS diagnosis from urine screening to enzymatic confirmation: results of a pilot study in Morocco. Clin Lab 66. https:\/\/doi.org\/10.7754\/Clin.Lab.2019.190720","DOI":"10.7754\/Clin.Lab.2019.190720"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/ped.14278","volume":"62","author":"E Sabir","year":"2020","unstructured":"Sabir E, Lafhal K, Ezoubeiri A et al (2020) Usefulness of urinary glycosaminoglycans assay for a mucopolysaccharidosis-specific screening. Pediatr Int 62:1077\u20131085","journal-title":"Pediatr Int"},{"key":"5_CR3","doi-asserted-by":"crossref","unstructured":"Shimada T, Tomatsu S, Mason RW, et al (2014) Di-sulfated keratan sulfate as a novel biomarker for mucopolysaccharidosis II, IVA, and IVB. In: JIMD reports, vol 21. Springer, pp 1\u201313","DOI":"10.1007\/8904_2014_330"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ymgme.2020.02.006","volume":"130","author":"E Kakkis","year":"2020","unstructured":"Kakkis E, Marsden D (2020) Urinary glycosaminoglycans as a potential biomarker for evaluating treatment efficacy in subjects with mucopolysaccharidoses. Mol Genet Metab 130:7\u201315","journal-title":"Mol Genet Metab"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1747-0285.2008.00741.x","volume":"72","author":"NS Gandhi","year":"2008","unstructured":"Gandhi NS, Mancera RL (2008) The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des 72:455\u2013482","journal-title":"Chem Biol Drug Des"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"5983","DOI":"10.3390\/ijms21175983","volume":"21","author":"J Wei","year":"2020","unstructured":"Wei J, Hu M, Huang K et al (2020) Roles of proteoglycans and glycosaminoglycans in cancer development and progression. Int J Mol Sci 21:5983","journal-title":"Int J Mol Sci"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"5793","DOI":"10.3390\/ijms23105793","volume":"23","author":"L Hillemeyer","year":"2022","unstructured":"Hillemeyer L, Espinoza-Sanchez NA, Greve B et al (2022) The cell surface heparan sulfate proteoglycan syndecan-3 promotes ovarian cancer pathogenesis. Int J Mol Sci 23:5793","journal-title":"Int J Mol Sci"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"607306","DOI":"10.3389\/fimmu.2021.607306","volume":"12","author":"PP Wadowski","year":"2021","unstructured":"Wadowski PP, Jilma B, Kopp CW et al (2021) Glycocalyx as possible limiting factor in COVID-19. Front Immunol 12:607306","journal-title":"Front Immunol"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/diseases9040085","volume":"9","author":"S Bauer","year":"2021","unstructured":"Bauer S, Zhang F, Linhardt RJ (2021) Implications of glycosaminoglycans on viral zoonotic diseases. Diseases 9:85","journal-title":"Diseases"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1172\/jci.insight.147472","volume":"6","author":"KA Queisser","year":"2021","unstructured":"Queisser KA, Mellema RA, Middleton EA et al (2021) COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction. JCI Insight 6:17","journal-title":"JCI Insight"}],"container-title":["Methods in Molecular Biology","Proteoglycans"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2946-8_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T04:01:40Z","timestamp":1674273700000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2946-8_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9781071629451","9781071629468"],"references-count":10,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2946-8_5","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"21 January 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}